Assetmark, Inc Ligand Pharmaceuticals Inc Transaction History

Assetmark, Inc

$45.6 Billion
Q3 2025

A detailed history of Assetmark, Inc transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Assetmark, Inc holds 123 shares of LGND stock, worth $24,705. This represents 0.0% of its overall portfolio holdings.

Number of Shares

123

Previous 48 156.25%

Holding current value

$24,705

Previous $5,000 320.0%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 06, 2025	BUY	$112.56 - $177.14 $8,442 - $13,285	75 Added 156.25%	123 $21,000
Q2 2025 Aug 04, 2025	BUY	$96.67 - $118.22 $2,126 - $2,600	22 Added 84.62%	48 $5,000
Q1 2025 May 06, 2025	SELL	$105.14 - $122.23 $6,098 - $7,089	-58 Reduced 69.05%	26 $2,000
Q4 2024 Feb 06, 2025	BUY	$99.95 - $129.9 $5,397 - $7,014	54 Added 180.0%	84 $9,000
Q3 2024 Nov 01, 2024	BUY	$82.7 - $110.11 $330 - $440	4 Added 15.38%	30 $3,000

Q1 2024 May 06, 2024	BUY	$68.64 - $89.2 $1,784 - $2,319	26 New	26 $1,000
Q1 2022 May 13, 2022	SELL	$94.99 - $151.56 $1,899 - $3,031	-20 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$127.69 - $165.85 $2,553 - $3,317	20 New	20 $3,000
Q4 2020 Feb 10, 2021	SELL	$80.55 - $106.05 $483 - $636	-6 Closed	0 $0
Q2 2020 Aug 11, 2020	SELL	$68.28 - $123.65 $158,341 - $286,744	-2,319 Reduced 99.74%	6 $1,000
Q1 2020 May 12, 2020	SELL	$63.37 - $107.88 $12,420 - $21,144	-196 Reduced 7.77%	2,325 $169,000
Q4 2019 Feb 11, 2020	BUY	$96.94 - $113.59 $213,655 - $250,352	2,204 Added 695.27%	2,521 $263,000
Q3 2019 Nov 13, 2019	BUY	$86.25 - $120.16 $26,823 - $37,369	311 Added 5183.33%	317 $32,000
Q1 2018 May 16, 2018	SELL	$138.63 - $182.62 $145,561 - $191,751	-1,050 Reduced 99.43%	6 $1,000
Q4 2017 Feb 13, 2018	BUY	$128.36 - $147.04 $104,485 - $119,690	814 Added 336.36%	1,056 $145,000
Q3 2017 Nov 08, 2017	SELL	$120.91 - $137.94 $1,692 - $1,931	-14 Reduced 5.47%	242 $33,000
Q2 2017 Aug 15, 2017	SELL	N/A	-1 Reduced 0.39%	256 $31,000
Q1 2017 Sep 15, 2017	SELL	N/A	-30 Reduced 10.45%	257 $27,000
Q4 2016 Sep 15, 2017	BUY	N/A	3 Added 1.06%	287 $29,000
Q3 2016 Sep 15, 2017	SELL	N/A	-32 Reduced 10.13%	284 $29,000
Q2 2016 Sep 15, 2017	BUY	N/A	178 Added 128.99%	316 $38,000
Q1 2016 Sep 15, 2017	BUY	N/A	119 Added 626.32%	138 $15,000
Q4 2015 Sep 15, 2017	BUY	N/A	19	19 $2,000

Others Institutions Holding LGND

# of Institutions

343

Shares Held

20.5M

Call Options Held

19K

Put Options Held

11.5K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $3.39B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.

Account